Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 12;20(1):66.
doi: 10.1186/s12954-023-00785-y.

'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England

Fleur Riley  1 , Magdalena Harris  2 , Hannah Louise Poulter  3 , Helen J Moore  3 , Daniel Ahmed  4 , Graham Towl  5 , Tammi Walker  5
Affiliations

'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England

Fleur Riley et al. Harm Reduct J. .

Abstract

Background: Heroin-Assisted Treatment (HAT) is well evidenced internationally to improve health and social outcomes for people dependent on opioids who have not been helped by traditional treatment options. Despite this evidence base, England has been slow to implement HAT. The first service outside of a trial setting opened in 2019, providing twice-daily supervised injections of medical-grade heroin (diamorphine) to a select sample of high-risk heroin users in Middlesbrough. This paper explores their experiences, including the negotiation of the strict regularly controls required of a novel intervention in the UK context.

Methods: We conducted in-depth interviews with service providers and users of the Middlesbrough HAT service between September and November 2021. Data from each group were thematically analysed and reported separately. This paper details the experiences of the twelve heroin dependent men and women accessing HAT.

Results: Participants' accounts of HAT treatment evidenced a tension between the regulatory constraints and uncertainty of treatment provision, and the positive outcomes experienced through supportive service provision and an injectable treatment option. Limited confidence was held in treatment efficacy, longevity of funding, and personal capacity for treatment success. This was counteracted by a strong motivation to cease engagement with the illicit drug market. While attendance requirements placed restrictions on daily activities, participants also experienced benefits from strong, supportive bonds built with the service providers through their continued engagement.

Conclusions: The Middlesbrough HAT programme provided benefits to a high-risk population of opioid dependent people who were unable or disinclined to participate in conventional opioid substitution treatments. The findings in this paper highlight the potential for service modifications to further enhance engagement. The closure of this programme in 2022 prohibits this opportunity for the Middlesbrough community, but holds potential to inform advocacy and innovation for future HAT interventions in England.

Keywords: Harm reduction; Heroin-Assisted Treatment; Injectable opioid therapy; Opioid dependency; People who inject drugs; Recovery.

PubMed Disclaimer

Conflict of interest statement

Daniel Ahmed (DA) works as clinical lead for Foundations Medical Practice which delivers HAT in Middlesbrough. DA was not part in the development of interview schedules, data collection, or analysis but contributed to reviewing final manuscript for context. DA was interviewed as part of the research to gather his perspectives as a practitioner by an external member of the research team so not to introduce bias during the interview process. This interview does not form part of the data used within the analysis presented in this paper.

References

    1. Public Health England. United Kingdom drug situation 2019: Focal Point annual report. 2021 [cited 2022 Nov 24]. Available from: https://www.gov.uk/government/publications/united-kingdom-drug-situation...
    1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug-related deaths and mortality in Europe. 2019 [cited 2022 Nov 24]. Available from: https://www.emcdda.europa.eu/system/files/publications/11485/20193286_TD...
    1. Office for National Statistics (ONS). Deaths related to drug poisoning in England and Wales: 2020 registrations. 2020 2021 [cited 2022 Nov 24]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarri...
    1. Poulter HL, Moore H, Crow R, Ahmed D, Walker T. Diamorphine assisted treatment in Middlesbrough: a UK drug treatment case study. J Subst Use. 2022;14:1–7. doi: 10.1080/14659891.2022.2120433. - DOI
    1. Nahar LK, Murphy KG, Paterson S. Misuse and mortality related to gabapentin and pregabalin are being under-estimated: a two-year post-mortem population study. J Anal Toxicol. 2019;43(7):564–570. doi: 10.1093/jat/bkz036. - DOI - PubMed